Cango Inc. Announces Completion of Secondary Acquisition and Appointment of New Leadership Team
HONG KONG, July 23, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) today…
Jyong Biotech Ltd. Announces Closing of $20 Million Initial Public Offering
New Taipei City, Taiwan, June 18, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech…
Energize Capital raises $430 million to capitalize and scale digitally-enabled climate solutions
Backed by leading institutional Limited Partners, Ventures Fund III underscores the need…
Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition…
Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde regimen in metastatic pancreatic adenocarcinoma
Phase III NAPOLI 3 trial is the largest and has the longest…